The interaction of Eap with intercellular adhesion molecules 1 (ICAM-1) leads to the inhibition of leukocytes binding to activated endothelial cells, as well as the movement of leukocytes from the bloodstream to the site of infection [101]. This evidence concerns the gene ICAM1 and infection.